ABVC BioPharma, Inc.
ABVC
$1.23
-$0.08-6.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.91M | -5.08M | -4.23M | -2.91M | -4.90M |
| Total Depreciation and Amortization | 504.70K | 168.40K | 178.80K | 212.30K | 200.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.03M | 3.49M | 2.60M | 1.39M | 3.30M |
| Change in Net Operating Assets | -615.30K | -851.30K | -629.50K | -89.20K | -408.50K |
| Cash from Operations | -2.99M | -2.27M | -2.08M | -1.39M | -1.81M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.21M | -1.48M | -164.20K | 0.00 | 0.00 |
| Cash from Investing | -1.21M | -1.48M | -164.20K | 0.00 | 0.00 |
| Total Debt Issued | 889.00K | 3.40K | -820.10K | 60.00K | 372.10K |
| Total Debt Repaid | -547.80K | -616.10K | -459.50K | -385.40K | -356.10K |
| Issuance of Common Stock | 4.30M | 3.84M | 3.30M | 1.39M | 978.50K |
| Repurchase of Common Stock | -- | -7.30K | -7.30K | -7.30K | -7.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 599.60K | 599.60K | 427.90K | 993.70K |
| Cash from Financing | 4.64M | 3.82M | 2.61M | 1.49M | 1.98M |
| Foreign Exchange rate Adjustments | 20.20K | 11.50K | -36.90K | 8.30K | -24.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 463.30K | 84.10K | 333.60K | 100.60K | 147.00K |